Stephen Hahn
#68,963
Most Influential Person Now
American radiation and medical oncologist
Stephen Hahn's AcademicInfluence.com Rankings
Stephen Hahnmedical Degrees
Medical
#886
World Rank
#1146
Historical Rank
#303
USA Rank
Oncology
#67
World Rank
#71
Historical Rank
#16
USA Rank
Download Badge
Medical
Stephen Hahn's Degrees
- Bachelors Biology Rice University
Similar Degrees You Can Earn
Why Is Stephen Hahn Influential?
(Suggest an Edit or Addition)According to Wikipedia, Stephen Michael Hahn is an American physician who served as the Commissioner of Food and Drugs from 2019 to 2021. Before becoming Commissioner, he was an oncologist serving as Chief Medical Executive of the MD Anderson Cancer Center. In 2021 he became Chief medical officer at the venture capital firm that launched Moderna.
Stephen Hahn's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- CA : A Cancer Journal for Clinicians (2011) (6703)
- Photodynamic therapy of cancer: An update (2011) (3628)
- Radiation and Dual Checkpoint Blockade Activates Non-Redundant Immune Mechanisms in Cancer (2015) (1835)
- National Institutes of Health State-of-the-Science Conference statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009. (2010) (349)
- Hypoxia Is Important in the Biology and Aggression of Human Glial Brain Tumors (2004) (320)
- Role of Chemical Structure in Fragility of Polymers: A Qualitative Picture (2008) (277)
- Improving immune–vascular crosstalk for cancer immunotherapy (2018) (253)
- Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy. (2005) (223)
- Inhibition of oxygen-dependent radiation-induced damage by the nitroxide superoxide dismutase mimic, tempol. (1991) (218)
- Tempol, a stable free radical, is a novel murine radiation protector. (1992) (216)
- Comparative Measurements of Hypoxia in Human Brain Tumors Using Needle Electrodes and EF5 Binding (2004) (212)
- Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer. (2018) (208)
- In vivo electron paramagnetic resonance imaging of tumor heterogeneity and oxygenation in a murine model. (1998) (170)
- Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small-cell lung carcinoma. (2001) (164)
- Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy. (2017) (160)
- Short-term and long-term health risks of nuclear-power-plant accidents. (2011) (153)
- Nelfinavir down-regulates hypoxia-inducible factor 1alpha and VEGF expression and increases tumor oxygenation: implications for radiotherapy. (2006) (150)
- The RAS signal transduction pathway and its role in radiation sensitivity (2003) (147)
- Farnesyltransferase inhibitors: an overview of the results of preclinical and clinical investigations. (2003) (147)
- Nitroxide stable radicals protect beating cardiomyocytes against oxidative damage. (1991) (142)
- Phosphatase and tensin homologue deficiency in glioblastoma confers resistance to radiation and temozolomide that is reversed by the protease inhibitor nelfinavir. (2007) (136)
- Radical pleurectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma. (2012) (134)
- Detection of brain tumor cells in the peripheral blood by a telomerase promoter-based assay. (2014) (132)
- An improved method for the diimide hydrogenation of butadiene and isoprene containing polymers (1992) (129)
- Depletion of tumor oxygenation during photodynamic therapy: detection by the hypoxia marker EF3 [2-(2-nitroimidazol-1[H]-yl)-N-(3,3,3-trifluoropropyl)acetamide ]. (2000) (127)
- Explicit dosimetry for photodynamic therapy: macroscopic singlet oxygen modeling (2010) (127)
- A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma. (2003) (126)
- Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non–Small Cell Lung Cancer: Final Results of a Phase 2 Study (2017) (126)
- Real-time In Situ Monitoring of Human Prostate Photodynamic Therapy with Diffuse Light (2006) (126)
- The HIV protease inhibitor nelfinavir downregulates Akt phosphorylation by inhibiting proteasomal activity and inducing the unfolded protein response. (2007) (124)
- Epidermal Growth Factor Receptor Inhibition Modulates the Microenvironment by Vascular Normalization to Improve Chemotherapy and Radiotherapy Efficacy (2009) (123)
- A Phase I Study of Topical Tempol for the Prevention of Alopecia Induced by Whole Brain Radiotherapy (2004) (123)
- Broadband reflectance measurements of light penetration, blood oxygenation, hemoglobin concentration, and drug concentration in human intraperitoneal tissues before and after photodynamic therapy. (2005) (117)
- 7‐year follow‐up after stereotactic ablative radiotherapy for patients with stage I non–small cell lung cancer: Results of a phase 2 clinical trial (2017) (112)
- Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases: A Randomized Phase 2 Trial. (2019) (112)
- A Phase II Trial of Intraperitoneal Photodynamic Therapy for Patients with Peritoneal Carcinomatosis and Sarcomatosis (2006) (109)
- The catecholic metal sequestering agent 1,2-dihydroxybenzene-3,5-disulfonate confers protection against oxidative cell damage. (1992) (106)
- Phase II trial of pleural photodynamic therapy and surgery for patients with non-small-cell lung cancer with pleural spread. (2004) (105)
- Immune Priming of the Tumor Microenvironment by Radiation. (2016) (104)
- Photodynamic therapy for the treatment of non-small cell lung cancer. (2012) (103)
- Tumor Cells Surviving Exposure to Proton or Photon Radiation Share a Common Immunogenic Modulation Signature, Rendering Them More Sensitive to T Cell-Mediated Killing. (2016) (103)
- Preliminary results of interstitial motexafin lutetium‐mediated PDT for prostate cancer (2006) (100)
- A low molecular weight antioxidant decreases weight and lowers tumor incidence. (2003) (97)
- Tracking viable circulating tumor cells (CTCs) in the peripheral blood of non–small cell lung cancer (NSCLC) patients undergoing definitive radiation therapy: Pilot study results (2015) (97)
- The Rise of Radiomics and Implications for Oncologic Management. (2017) (96)
- Motexafin Lutetium-Photodynamic Therapy of Prostate Cancer: Short- and Long-Term Effects on Prostate-Specific Antigen (2008) (93)
- Photofrin Uptake in the Tumor and Normal Tissues of Patients Receiving Intraperitoneal Photodynamic Therapy (2006) (92)
- Optical Properties of Human Prostate at 732 nm Measured In Vivo During Motexafin Lutetium–mediated Photodynamic Therapy¶ (2005) (92)
- Extended Pleurectomy-Decortication-Based Treatment for Advanced Stage Epithelial Mesothelioma Yielding a Median Survival of Nearly Three Years. (2017) (92)
- A Phase I trial of the farnesyltransferase inhibitor L-778,123 and radiotherapy for locally advanced lung and head and neck cancer. (2002) (91)
- Awakening the immune system with radiation: Optimal dose and fractionation. (2015) (89)
- Effect of Chain Architecture and Surface Energies on the Ordering Behavior of Lamellar and Cylinder Forming Block Copolymers (2006) (88)
- Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment (2019) (87)
- Evaluation of the hydroxylamine Tempol-H as an in vivo radioprotector. (2000) (87)
- Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity. (1993) (86)
- ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016 (2016) (86)
- Patient‐reported outcomes after 3‐dimensional conformal, intensity‐modulated, or proton beam radiotherapy for localized prostate cancer (2013) (85)
- Evaluation of tempol radioprotection in a murine tumor model. (1997) (85)
- Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model. (1999) (83)
- Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes. (2010) (82)
- Farnesyltransferase inhibitors. (2001) (81)
- A Phase I Trial of the Dual Farnesyltransferase and Geranylgeranyltransferase Inhibitor L-778,123 and Radiotherapy for Locally Advanced Pancreatic Cancer (2004) (78)
- A Phase I Trial of the HIV Protease Inhibitor Nelfinavir with Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer: A Report of Toxicities and Clinical Response (2012) (76)
- Pancreatic cancer cell radiation survival and prenyltransferase inhibition: the role of K-Ras. (2005) (75)
- Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer. (2006) (74)
- Hemodynamic effect of the nitroxide superoxide dismutase mimics. (1999) (74)
- Interstitial Fluorescence Spectroscopy in the Human Prostate During Motexafin Lutetium–Mediated Photodynamic Therapy (2006) (73)
- Identification of nitroxide radioprotectors. (1992) (73)
- NIH state-of-the-science conference statement: diagnosis and management of ductal carcinoma in situ (DCIS). (2009) (72)
- Catalytic Hydrogenation of Polystyrene (2000) (71)
- In vivo reflectance measurement of optical properties, blood oxygenation and motexafin lutetium uptake in canine large bowels, kidneys and prostates. (2002) (70)
- Supply and Demand for Radiation Oncology in the United States: Updated Projections for 2015 to 2025. (2016) (70)
- A case‐matched study of toxicity outcomes after proton therapy and intensity‐modulated radiation therapy for prostate cancer (2015) (69)
- A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours (2018) (69)
- Optimized interstitial PDT prostate treatment planning with the Cimmino feasibility algorithm. (2005) (68)
- In vivo light dosimetry for motexafin lutetium‐mediated PDT of recurrent breast cancer (2002) (68)
- Potential use of nitroxides in radiation oncology. (1994) (68)
- Phase II Trial of Debulking Surgery and Photodynamic Therapy for Disseminated Intraperitoneal Tumors (2001) (67)
- Photodynamic therapy in the canine prostate using motexafin lutetium. (2001) (66)
- Multi‐Institutional Prospective Study of Reirradiation with Proton Beam Radiotherapy for Locoregionally Recurrent Non–Small Cell Lung Cancer (2017) (66)
- Gold nanoparticles in radiation research: potential applications for imaging and radiosensitization. (2013) (66)
- Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation–Related Abscopal Responses (2019) (65)
- Effect of End-Anchored Chains on the Adhesion at a Thermoset-Thermoplastic Interface (1995) (65)
- Efficacy and safety of stereotactic body radiation therapy for the treatment of pulmonary metastases from sarcoma: A potential alternative to resection (2016) (63)
- PCHE-based pentablock copolymers : Evolution of a new plastic (2001) (62)
- Modulation of CCAAT/Enhancer Binding Protein Homologous Protein (CHOP)-dependent DR5 Expression by Nelfinavir Sensitizes Glioblastoma Multiforme Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)* (2011) (61)
- Comparison between isotropic and nonisotropic dosimetry systems during intraperitoneal photodynamic therapy (2000) (61)
- Photodynamic therapy and the evolution of a lung-sparing surgical treatment for mesothelioma. (2011) (60)
- Patterns and levels of hypoxia in head and neck squamous cell carcinomas and their relationship to patient outcome. (2007) (59)
- Spin trap salvage from endotoxemia: the role of cytokine down-regulation. (1992) (58)
- Hypoxia and Photofrin Uptake in the Intraperitoneal Carcinomatosis and Sarcomatosis of Photodynamic Therapy Patients (2004) (58)
- EF5 binding and clinical outcome in human soft tissue sarcomas. (2006) (58)
- Effects of molecular weight and thermal history on scratch behavior of polypropylene thin sheets (2008) (57)
- Stereotactic body radiation therapy for lung cancer. (2013) (56)
- In vivo Optical Properties of Normal Canine Prostate at 732 nm Using Motexafin Lutetium–mediated Photodynamic Therapy¶ (2003) (56)
- Role of Molecular Architecture in Mechanical Failure of Glassy/Semicrystalline Block Copolymers: CEC vs CECEC Lamellae (2003) (56)
- Taxol in combination with doxorubicin or etoposide possible antagonism in vitro (1993) (55)
- Elevated Serum Cytokine Levels in Mesothelioma Patients Who Have Undergone Pleurectomy or Extrapleural Pneumonectomy and Adjuvant Intraoperative Photodynamic Therapy¶ (2003) (54)
- Topical application of nitroxide protects radiation-induced alopecia in guinea pigs. (1992) (54)
- In vivo radioprotection and effects on blood pressure of the stable free radical nitroxides. (1998) (53)
- Technology for Innovation in Radiation Oncology. (2015) (53)
- Imaging and Analytical Methods as Applied to the Evaluation of Vasculature and Hypoxia in Human Brain Tumors (2008) (53)
- Biodistribution and dosimetry of 18F-EF5 in cancer patients with preliminary comparison of 18F-EF5 uptake versus EF5 binding in human glioblastoma (2010) (53)
- Phase II trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. (2001) (52)
- Intraperitoneal photodynamic therapy. (2007) (51)
- The Relationship among Hypoxia, Proliferation, and Outcome in Patients with De Novo Glioblastoma: A Pilot Study. (2010) (51)
- Chain architecture effects on deformation and fracture of block copolymers with unentangled matrices. (2002) (50)
- Adjustment of Block Copolymer Nanodomain Sizes at Lattice Defect Sites (2003) (50)
- Cost‐effectiveness of stereotactic body radiation therapy versus surgical resection for stage I non–small cell lung cancer (2013) (50)
- Long‐Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non–Small Cell Lung Cancer: A Phase II Clinical Trial (2017) (47)
- Ras inhibitors and radiation therapy. (2001) (46)
- Optical properties of human prostate at 732 nm measured in mediated photodynamic therapy. (2005) (46)
- Hypoxia in human intraperitoneal and extremity sarcomas. (2001) (46)
- Tempol inhibits neutrophil and hydrogen peroxide-mediated DNA damage. (1997) (44)
- Patterns of recurrence in patients treated with photodynamic therapy for intraperitoneal carcinomatosis and sarcomatosis. (2004) (44)
- Cancer patients use unconventional medical therapies far more frequently than standard history and physical examination suggest. (2001) (44)
- Signaling Pathways in NSCLC as a Predictor of Outcome and Response to Therapy (2004) (44)
- Should randomized clinical trials be required for proton radiotherapy? An alternative view. (2008) (43)
- Phase 1 trial of preoperative image guided intensity modulated proton radiation therapy with simultaneously integrated boost to the high risk margin for retroperitoneal sarcomas (2017) (43)
- Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer (2018) (43)
- Adjuvant radiotherapy for completely resected stage 2 thymoma (2011) (41)
- Non-small cell lung cancer: prognostic factors in patients treated with surgery and postoperative radiation therapy. (1999) (41)
- Rates of unconventional medical therapy use in patients with prostate cancer: standard history versus directed questions. (2002) (40)
- Development of investigational radiation modifiers. (2003) (39)
- Cervical Cancer in Botswana: Current State and Future Steps for Screening and Treatment Programs (2015) (39)
- Bayesian randomized trial comparing intensity modulated radiation therapy versus passively scattered proton therapy for locally advanced non-small cell lung cancer. (2016) (39)
- Preclinical Rationale and Clinical Considerations for Radiotherapy Plus Immunotherapy: Going Beyond Local Control. (2016) (39)
- Correlation of in vivo photosensitizer fluorescence and photodynamic-therapy-induced depth of necrosis in a murine tumor model. (2003) (38)
- Theranostic gold nanoparticles modified for durable systemic circulation effectively and safely enhance the radiation therapy of human sarcoma cells and tumors. (2013) (38)
- Molecular Weight Effects in the Hydrogenation of Model Polystyrenes Using Platinum Supported on Wide-Pore Silica (2002) (38)
- Acyclic diene metathesis (ADMET) polymerization. Synthesis of perfectly linear polyethylene (1993) (38)
- Increasing the Therapeutic Ratio of Stereotactic Ablative Radiotherapy by Individualized Isotoxic Dose Prescription. (2016) (38)
- Free radical modes of cytotoxicity of adriamycin and streptonigrin. (1994) (38)
- Hypoxia imaging markers and applications for radiation treatment planning. (2012) (37)
- Prospective preference assessment of patients' willingness to participate in a randomized controlled trial of intensity-modulated radiotherapy versus proton therapy for localized prostate cancer. (2011) (37)
- Phase I study of paclitaxel as a radiation sensitizer in the treatment of mesothelioma and non-small-cell lung cancer. (1998) (37)
- Reference pricing with evidence development: a way forward for proton therapy. (2014) (36)
- Microstructure of Ionomers based on Sulfonated Block Copolymers of Polystyrene and Poly(ethylene-alt-propylene) (1999) (36)
- Adjuvant Radiotherapy in the Treatment of Invasive Intraductal Papillary Mucinous Neoplasm of the Pancreas: an Analysis of the Surveillance, Epidemiology, and End Results Registry (2012) (36)
- Concurrent segmentation of the prostate on MRI and CT via linked statistical shape models for radiotherapy planning. (2012) (35)
- Barriers to Combined-Modality Therapy for Limited-Stage Small Cell Lung Cancer (2018) (35)
- Comparative treatment planning between proton and X-ray therapy in pancreatic cancer. (2001) (35)
- Farnesyltransferase inhibitors as radiation sensitizers. (2002) (33)
- Spatial Dose Patterns Associated With Radiation Pneumonitis in a Randomized Trial Comparing Intensity-Modulated Photon Therapy With Passive Scattering Proton Therapy for Locally Advanced Non-Small Cell Lung Cancer. (2019) (33)
- Thermally induced polymerization of an arylvinylbenzocyclobutene monomer (1992) (33)
- The International Cancer Expert Corps: A Unique Approach for Sustainable Cancer Care in Low and Lower-Middle Income Countries (2014) (33)
- Shear-induced lamellae alignment in matched triblock and pentablock copolymers (2002) (33)
- Clinical Development of Novel Drug–Radiotherapy Combinations (2018) (33)
- Stereotactic Ablative Radiation Therapy is Highly Safe and Effective for Elderly Patients With Early-stage Non-Small Cell Lung Cancer. (2017) (33)
- Vascularity and uptake of photosensitizer in small human tumor nodules: implications for intraperitoneal photodynamic therapy. (2001) (32)
- Preliminary Report of Photodynamic Therapy for Intraperitoneal Sarcomatosis (2001) (31)
- A phase I study of nelfinavir concurrent with temozolomide and radiotherapy in patients with glioblastoma multiforme (2013) (31)
- Long-term outcome of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer. (2017) (31)
- Effect of thermal history and microdomain orientation on deformation and fracture properties of poly(cyclohexylethylene)-polyethylene triblock copolymers containing cylindrical PE domains (2002) (31)
- Control of the block copolymer morphology in templated epoxy thermosets (2007) (31)
- Thermal polymerization of bis(benzocyclobutene) monomers containing .alpha.,.beta.-disubstituted ethenes (1993) (31)
- Extrapleural pneumonectomy, photodynamic therapy and intensity modulated radiation therapy for the treatment of malignant pleural mesothelioma (2010) (30)
- Five‐year Long‐term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non–small‐cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor Location (2019) (30)
- Optimization of light source parameters in the photodynamic therapy of heterogeneous prostate (2008) (30)
- ADMET Modeling of Branching in Polyethylene. The Effect of a Perfectly-Spaced Methyl Group (1997) (30)
- Proton pencil beam scanning for mediastinal lymphoma: treatment planning and robustness assessment (2016) (29)
- Toxicity of photodynamic therapy after combined external beam radiotherapy and intraluminal brachytherapy for carcinoma of the upper aerodigestive tract (2001) (29)
- Proton pencil beam scanning for mediastinal lymphoma: the impact of interplay between target motion and beam scanning (2015) (29)
- Radiation Sensitization by Inhibition of Activated Ras (2004) (29)
- Circulating Tumor Cells Are Associated with Recurrent Disease in Patients with Early-Stage Non–Small Cell Lung Cancer Treated with Stereotactic Body Radiotherapy (2020) (28)
- Taxol in Combination with Doxorubicin or Etoposide (1993) (28)
- Current status and recommendations for the future of research, teaching, and testing in the biological sciences of radiation oncology: report of the American Society for Radiation Oncology Cancer Biology/Radiation Biology Task Force, executive summary. (2014) (27)
- Principles and reality of proton therapy treatment allocation. (2014) (27)
- Intraperitoneal Photodynamic Therapy Causes a Capillary-Leak Syndrome (2003) (27)
- Phase I trial of motexafin-lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer (2004) (26)
- A research agenda for radiation oncology: results of the radiation oncology institute's comprehensive research needs assessment. (2012) (26)
- Qualitative Assessment of Academic Radiation Oncology Department Chairs' Insights on Diversity, Equity, and Inclusion: Progress, Challenges, and Future Aspirations. (2018) (26)
- A prospective study of proton reirradiation for recurrent and secondary soft tissue sarcoma. (2017) (25)
- Farnesyltransferase inhibitors as radiation sensitizers (2003) (25)
- Burnout in United States academic chairs of radiation oncology programs. (2014) (24)
- Implications of comparative effectiveness research for radiation oncology. (2011) (24)
- Photodynamic therapy for mesothelioma (2001) (24)
- The emergence of photodynamic therapy as a major modality in cancer treatment (1999) (24)
- Thermal and Viscoelastic Behavior of Hydrogenated Polystyrene (2001) (24)
- Styrene 4-vinylbenzocyclobutene copolymer for microelectronic applications (2008) (23)
- Photodynamic therapy with motexafin lutetium for rectal cancer: a preclinical model in the dog. (2006) (23)
- Interstitial photodynamic therapy for prostate cancer: a developing modality. (2004) (23)
- Preclinical evaluation of motexafin lutetium-mediated intraperitoneal photodynamic therapy in a canine model. (2001) (22)
- Phase I trial of concurrent stereotactic body radiotherapy and nelfinavir for locally advanced borderline or unresectable pancreatic adenocarcinoma. (2019) (22)
- Reirradiation of thoracic cancers with intensity modulated proton therapy. (2018) (22)
- Clinical Outcomes of the HIV Protease Inhibitor Nelfinavir With Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer: A Phase 1/2 Trial. (2019) (22)
- Benzocyclobutene interlayer dielectrics for thin film multichip modules (1990) (22)
- Synthesis of Conductive Nanocomposites by Selective In Situ Polymerization of Pyrrole within the Lamellar Microdomains of a Block Copolymer (1998) (21)
- Training Global Oncologists: Addressing the Global Cancer Control Problem (2015) (21)
- Application of a telomerase-based circulating tumor cell (CTC) assay in bladder cancer patients receiving postoperative radiation therapy (2014) (21)
- In vivo determination of the absorption and scattering spectra of the human prostate during photodynamic therapy (2004) (21)
- Neurophysiological consequences of nitroxide antioxidants. (1995) (21)
- Pathological Response to Preoperative Chemoradiation Worsens with Anemia in Non‐‐‐Small Cell Lung Cancer Patients (2002) (20)
- In vivo light dosimetry for pleural PDT (2009) (20)
- A multidrug-resistant breast cancer cell line induced by weekly exposure to doxorubicin. (1999) (19)
- Mn(III)-desferrioxamine superoxide dismutase-mimic: alternative modes of action. (1991) (19)
- Diffuse reflectance spectra measured in vivo in human tissues during Photofrin-mediated pleural photodynamic therapy (2006) (19)
- Phase 2 5-Arm Trial of Ipilimumab Plus Lung or Liver Stereotactic Radiation for Patients with Advanced Malignancies (2017) (19)
- Radiation dosimetry and biodistribution of the hypoxia tracer (18)F-EF5 in oncologic patients. (2012) (18)
- Incident learning in pursuit of high reliability: implementing a comprehensive, low-threshold reporting program in a large, multisite radiation oncology department. (2015) (18)
- New strategies in non-small cell lung cancer: improving outcomes in chemoradiotherapy for locally advanced disease. (2011) (18)
- High Glass Transition Temperature Polyolefins Obtained by the Catalytic Hydrogenation of Polyindene (2003) (18)
- Proton therapy for head and neck cancer: current applications and future directions (2012) (18)
- Gender, Professional Experiences, and Personal Characteristics of Academic Radiation Oncology Chairs: Data to Inform the Pipeline for the 21st Century. (2019) (18)
- Phase behavior of polystyrene/polybutadiene and polystyrene/hydrogenated polybutadiene mixtures : Effect of the microstructure of polybutadiene (1998) (17)
- Protection against Adriamycin cytotoxicity and inhibition of DNA topoisomerase II activity by 3,4-dihydroxybenzoic acid. (2003) (17)
- Biologically Effective Dose in Stereotactic Body Radiotherapy and Survival for Patients with Early-Stage Non-Small Cell Lung Cancer. (2019) (16)
- Global Radiotherapy: Current Status and Future Directions—White Paper (2021) (16)
- Early Detection of Recurrence in Patients With Locally Advanced Non-Small-Cell Lung Cancer via Circulating Tumor Cell Analysis. (2019) (16)
- Quantitative comparison of tissue oxygen and motexafin lutetium uptake by ex vivo and noninvasive in vivo techniques in patients with intraperitoneal carcinomatosis. (2007) (16)
- Cost-Effectiveness of Stereotactic Body Radiation Therapy Versus Surgical Resection for Stage I Non-Small Cell Lung Cancer (2013) (16)
- Isolating the Effects of Morphology and Chain Architecture on the Mechanical Properties of Triblock Copolymers (2006) (15)
- Assessing the Quality of a Radiation Oncology Case-Based, Peer-Review Program in an Integrated Academic and Community Cancer Center Network. (2016) (15)
- NTCP Models for Severe Radiation Induced Dermatitis After IMRT or Proton Therapy for Thoracic Cancer Patients (2020) (15)
- Combined Modality Therapy in the Elderly Population (2009) (15)
- Circulating Tumor Cell Assessment in Presumed Early Stage Non-Small Cell Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy: A Prospective Pilot Study. (2018) (15)
- Multi‐institutional analysis of stereotactic body radiotherapy for sarcoma pulmonary metastases: High rates of local control with favorable toxicity (2020) (15)
- Results of a Phase II Randomized Trial of Proton Beam Therapy vs Intensity Modulated Radiation Therapy in Esophageal Cancer (2019) (15)
- Hemithoracic Radiotherapy After Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma: A Dosimetric Comparison of Two Well-Described Techniques (2009) (15)
- The body of evidence for advanced technology in radiation oncology. (2013) (15)
- Prospective Trial of Circulating Tumor Cells as a Biomarker for Early Detection of Recurrence in Patients with Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiation Therapy. (2017) (14)
- C225 and PDT combination therapy for ovarian cancer: the play's the thing. (2005) (14)
- The implementation and assessment of a quality and safety culture education program in a large radiation oncology department. (2016) (14)
- New directions for free radical cancer research and medical applications. (1994) (13)
- A Novel Approach for the Detection and Genetic Analysis of Live Melanoma Circulating Tumor Cells (2015) (13)
- In vivo light dosimetry for HPPH-mediated pleural PDT (2010) (13)
- Evidence for a Thermally Reversible Order-Order Transition Between Lamellar and Perforated Lamellar Microphases in a Triblock Copolymer (2000) (12)
- An IR navigation system for real-time treatment guidance of pleural PDT (2011) (12)
- Processing and Properties of Polyolefin Elastomers and Fully Hydrogenated Styrenic Block Copolymer Elastomers (2000) (12)
- Clinical target promiscuity: lessons from ras molecular trials (2008) (12)
- Chemoradiotherapy-induced hemoglobin nadir values and survival in patients with stage III non-small cell lung cancer. (2018) (12)
- Reirradiation of Thoracic Cancers with Intensity Modulated Proton Therapy. (2017) (12)
- Extrusion of triblock and pentablock copolymers: Evolution of bulk and surface morphology (2005) (12)
- Commentary: Multidrug resistance in photodynamic therapy (2005) (12)
- Light dosimetry at tissue surfaces for small circular fields (2003) (11)
- Detector calibration factor for interstitial in vivo light dosimetry using isotropic detectors with scattering tip (2005) (11)
- Multichip thin-film technology on silicon (1989) (11)
- Is there a role for salvage radiotherapy in locally advanced breast cancer refractory to neoadjuvant chemotherapy? (2017) (11)
- In vivo light dosimetry of interstitial PDT of human prostate (2006) (10)
- Emotional Intelligence and Burnout in Academic Radiation Oncology Chairs (2017) (10)
- Proton therapy for head and neck cancer (2015) (9)
- Journey Toward High Reliability: A Comprehensive Safety Program to Improve Quality of Care and Safety Culture in a Large, Multisite Radiation Oncology Department. (2016) (9)
- Redoubling Efforts to Help Americans Quit Smoking - Federal Initiatives to Tackle the Country's Longest-Running Epidemic. (2020) (9)
- Microstructure of Block Copolymers of Polystyrene and Poly(ethylene-alt-propylene) (1998) (9)
- Thin-film silicon multichip technology (1988) (8)
- Apparent relaxation‐time spectrum cutoff in dilute polymer solutions: An effect of solvent dynamics (2001) (8)
- Polymorphisms in BMP2/BMP4, with estimates of mean lung dose, predict radiation pneumonitis among patients receiving definitive radiotherapy for non-small cell lung cancer (2017) (8)
- Proton beam therapy: the next disruptive innovation in healthcare? (2015) (7)
- A Glimpse of the Future: Where Will New Combinations of Diagnostics and Therapies Take Us? (2011) (7)
- The Processing and Properties of Multilayer Interconnection Structures Using Thermoset Films Derived from Bisbenzocyclobutene. (1989) (7)
- Galectin-1 and Immune Suppression during Radiotherapy (2014) (7)
- Harnessing and Optimizing the Interplay between Immunotherapy and Radiotherapy to Improve Survival Outcomes (2018) (7)
- Introduction: non-small-cell lung cancer and pleural malignancies: the end of the era of therapeutic nihilism? (2010) (7)
- Raising the next generation of physician-scientists: the chairs' perspective. (2015) (7)
- Preclinical Evaluation of Cetuximab and Benzoporphyrin Derivative‐Mediated Intraperitoneal Photodynamic Therapy in a Canine Model (2020) (7)
- The Pulmonary Fibrosis Associated MUC5B Promoter Polymorphism Is Prognostic of the Overall Survival in Patients with Non–Small Cell Lung Cancer (NSCLC) Receiving Definitive Radiotherapy123 (2017) (7)
- Photodynamic Therapy: A Light in the Darkness? (2009) (7)
- In-vivo measurements of penetration depth, oxygenation, and drug concentration using broadband absorption spectroscopy in human tissues before and after photodynamic therapy (2003) (6)
- 2035 A phase I study of paclitaxel as a radiation sensitizer for the treatment of non-small cell lung cancer and mesothelioma (1995) (6)
- Light dosimetry at tissue surfaces for oblique incident circular fields (2004) (6)
- Protection of mitomycin C induced skin extravasation with the nitroxide, 3-carbamoyl-PROXYL (3-CP). (1997) (6)
- Microdeformation behavior in nanotemplated epoxy thermosets: A study with in situ tensile deformation technique in transmission electron microscopy (2009) (6)
- A Roadmap for a New Academic Pathway for Global Radiation Oncology. (2015) (6)
- Phase I trial of the farnesyl protein transferase (FPTASE) inhibitor L-778123 in combination with radiotherapy (2000) (6)
- Effect of the Microstructure of Polydiene Block on Order−Disorder Transition in Diblock Copolymers Containing Polystyrene Block or Poly(vinylcyclohexane) Block (2004) (6)
- A fork in the road: choosing the path of relevance. (2015) (6)
- Diffuse reflectance spectra measured in vivo in human tissues during Photofrin-mediated pleural photodynamic therapy: updated results (2009) (6)
- Multidrug resistance in photodynamic therapy. (2005) (5)
- 2070 : 18F EF5 PET Imaging With Immunohistochemical Validation in Patients With Brain Lesions (2006) (5)
- In vivo measurement of fluorescence emission in the human prostate during photodynamic therapy (2005) (5)
- Signaling inhibition with radiation in colorectal cancer: Clinical trials (2003) (5)
- Chain architecture effects on the diffusion of cylinder-forming block copolymers (2007) (5)
- A real-time treatment guidance system for pleural PDT (2012) (5)
- Phase 1 Study of Pembrolizumab and Stereotactic or Hypofractionated Radiation for Metastatic Non–small Cell Lung Cancer (2017) (5)
- Deformation and Fracture of Lamellar and Cylindrical Block Copolymers with Unentangled Glassy Matrices: Effect of Chain Architecture and Microdomain Orientation (2006) (5)
- Radiation Therapy is Independently Associated with Worse Survival After R0-Resection for Stage I–II Non-small Cell Lung Cancer: An Analysis of the National Cancer Data Base (2017) (5)
- The Potential of Heavy-Ion Therapy to Improve Outcomes for Locally Advanced Non-Small Cell Lung Cancer (2017) (5)
- An automated electronic system for managing radiation treatment plan peer review reduces missed reviews at a large, high-volume academic center. (2016) (5)
- Nomograms incorporating genetic variants in BMP/Smad4/Hamp pathway to predict disease outcomes after definitive radiotherapy for non‐small cell lung cancer (2018) (4)
- Hydrogenated poly(styrene-co-α-methylstyrene) polymers: A new class of high glass-transition-temperature polyolefins (2003) (4)
- Photoimmunotherapy and ovarian cancer: an improbable fiction or a palpable hit? (1999) (4)
- The Gut and Cervical Microbiome Promote Immune Activation and Response to Chemoradiation in Cervical Cancer (2018) (4)
- Spectroscopic evaluation of photodynamic therapy of the intraperitoneal cavity (2010) (4)
- Computer-assisted targeted therapy (CATT) for prostate radiotherapy planning by fusion of CT and MRI (2010) (4)
- Salvage guideline for local-regional failure after stereotactic ablative radiotherapy for early-stage non-small cell lung cancer. (2017) (4)
- Hydrogenated Polystyrene: Preparation and Properties (2003) (4)
- Oral Scientific SessionsRectal Microbiome Diversity Predicts Disease Response at Completion of Radiation Therapy for Squamous Cell Carcinoma of the Cervix (2017) (4)
- Clonal Expansion of Antigen Specific T-Cells during Radiation Therapy for HPV Associated Cervical Cancers Is Regulated By the Vaginal Microbiome (2018) (3)
- GENERAL PRINCIPLES OF RADIATION AND CHEMORADIATION (2009) (3)
- Dosimetric Analysis of Randomized Proton and Photon Plans with Respect to Radiation Toxicity: The Importance of High Dose Regions in Lung and Esophagus. (2017) (3)
- Signaling inhibition with radiation in colorectal cancer: clinical trials. (2003) (3)
- Factors associated with event reporting in the pediatric radiation oncology population using an electronic incident reporting system. (2015) (3)
- Implications for Radiotherapy VEGF Expression and Increases Tumor Oxygenation : and α Nelfinavir Down-regulates Hypoxia-Inducible Factor 1 (2006) (3)
- Multi-institutional study of reirradiation with proton beam radiotherapy for non-small cell lung cancer. (2013) (3)
- Optimization of light sources for prostate photodynamic therapy (2005) (3)
- Elevated Serum Cytokine Levels in Mesothelioma Patients Who Have Undergone Pleurectomy or Extrapleural Pneumonectomy and Adjuvant Intraoperative Photodynamic Therapy ¶ (2003) (3)
- Novel polymeric structures via the chlorination of cis-1,4-polybutadiene in the presence of aryl nucleophiles (1993) (3)
- Variations in Proton Therapy Coverage in the State of Texas: Defining Medical Necessity for a Safe and Effective Treatment. (2016) (3)
- First Report of Real-time Tumor Tracking in the Treatment of Pancreatic Cancer using the Calypso System (2009) (3)
- OC-0143: A Bayesian randomisation trial of IMRT vs. PSPT for locally advanced non-small cell lung carcinoma (2016) (3)
- A heterogeneous algorithm for PDT dose optimization for prostate (2009) (3)
- Linked Statistical Shape Models for multi-modal segmentation of the prostate on MRI-CT for radiotherapy planning (2011) (2)
- Birefringent properties of cyclic block copolymers and low‐retardation‐film development (2010) (2)
- Effect of Saturation of Polydienes with Varying Microstructures on the Phase Behavior of Poly(vinylcyclohexane)/Poly(ethylene-alt-propylene) and Poly(vinylcyclohexane)/Poly(ethylene-co-1-butene) Blends (2002) (2)
- Clinical Outcome of Intensity Modulated Proton Therapy for Non-Small Cell Lung Cancer (2015) (2)
- Thoracic radiation oncology clinical trial accrual and reasons for non-enrollment: results of a large, prospective, multi-year analysis. (2020) (2)
- A Phase I Trial of the HIV Protease Inhibitor Nelfinavir with Concurrent Chemoradiotherapy (CT-RT) for Stage IIIA/IIIB NSCLC: A Report of Toxicities and Metabolic Response (2009) (2)
- Long-term Results of a Phase I/II Trial of Nelfinavir with Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer (2018) (2)
- Stereotactic Body Radiation Therapy (SBRT) for Stage I Non-Small Cell Lung Cancer (NSCLC): Outcomes by Fractionation, Tumor Stage and Location, and Patient Operability (2014) (2)
- American Board of Radiology Maintenance of Certification Program: Evolution to Better Serve Stakeholders. (2016) (2)
- Improving Safety Culture Through Incident Reporting (2012) (2)
- Analysis of PD-L1 and RAD50 in circulating cells recovered from lung cancer patients before and after induction of radiotherapy. (2016) (2)
- NIH State-of-the-Science Conference Statement (2009) (2)
- How important are willingness to participate studies in encouraging patient enrollment in oncology trials (2014) (2)
- Severe Radiation Induced Dermatitis after IMRT or Proton Therapy for Thoracic Cancer Patients (2019) (2)
- A phase I trial of the farnesyltransferase and geranylgeranyltransferase-I inhibitor L-778,123 (L-778) and radiotherapy for locally advanced pancreatic cancer. (2004) (2)
- Effect of SMURF2 Targeting on Susceptibility to MEK Inhibitors in Melanoma (2013) (2)
- Multi-institutional Analysis of Stereotactic Body Radiation Therapy for Sarcoma Pulmonary Metastases: High Rates of Local Control with Favorable Toxicity (2018) (2)
- Capturing Acquired Wisdom, Enabling Healthful Aging, and Building Multinational Partnerships Through Senior Global Health Mentorship (2020) (2)
- What's in a Label? Radioimmunotherapy for Metastatic Prostate Cancer (2013) (2)
- Ratio of the spherical and flat detectors at tissue surfaces during pleural photodynamic therapy (2002) (2)
- Making Admission or Placement Determinations Based on Sex in Facilities Under Community Planning and Development Housing Programs (2020) (2)
- A heterogeneous optimization algorithm for reacted singlet oxygen for interstitial PDT (2010) (2)
- Two-dimensional/three-dimensional hybrid interstitial diffuse optical tomography of human prostate during photodynamic therapy: phantom and clinical results (2007) (2)
- Protection against mitomycin C induced cytotoxicity by the stable nitroxide radical tempol (1990) (2)
- In vivo Optical Properties of Normal Canine Prostate at 732 nm Using Motexafin Lutetium–mediated Photodynamic Therapy ¶ (2003) (2)
- Future developments in radiation oncology for the management of carcinoma of the lung (1993) (1)
- Efficiency and Efficacy of Intensity Modulated Treatments on a Novel Linear Accelerator (2017) (1)
- Radiation Therapy is Independently Associated With Worse Survival After R0 Resection for Stage I-II Non-Small Cell Lung cancer: An Analysis of the National Cancer Data Base. (2017) (1)
- Phase 1 Study of Ipilimumab and Stereotactic Radiation Targeting Liver or Lung Lesions in Patients With Advanced Malignancies (2015) (1)
- Snapshot of a Specialty: Results of the ABR 2016 Radiation Oncology Clinical Practice Analysis. (2019) (1)
- Abstract A056: Mechanisms of tumor response and resistance to radiation and dual checkpoint blockade in mice and patients (2016) (1)
- Phase I Trial Utilizing Motexafin Lutetium Mediated PDT for Recurrent Prostate Cancer (2008) (1)
- Potential Use of Nitroxides in Radiation Oncology 1 (2006) (1)
- Comparison of Intensity Modulated Radiation Therapy, Adaptive Radiation Therapy, Proton Radiation Therapy, and Adaptive Proton Radiation Therapy for Small Cell Lung Cancer (2013) (1)
- Development of Elastomers Based on Fully Hydrogenated Styrene–Diene Block Copolymers (2004) (1)
- Radiation-Induced Malignant Mesothelioma: Frequency and Prognosis (2014) (1)
- Oral Scientific SessionsIncreased Diversity of the Intestinal Microbiome Predicts for Lower Rates of Patient Reported Acute Gastrointestinal Toxicity in Women Receiving Radiation Therapy for Cervical Cancer (2017) (1)
- 215 : Nelfinavir Downregulates HIF-1alpha and VEGF expression and Increases Tumor Oxygenation: Implications for Radiotherapy (2006) (1)
- Intraperitoneal PDT for the Treatment of Recurrent Ovarian Cancer (2000) (1)
- Molecular Biology and Genetics of Lung Cancer (2005) (1)
- A Phase I Trial of Pembrolizumab with Hypofractionated Radiation Therapy (HFRT) in Patients with Metastatic Cancers (2018) (1)
- Methods for Nanopatterning and Lithography (2011) (1)
- Phase I combination trial of gemcitabine, paclitaxel, and carboplatin in patients with advanced malignancy (2003) (1)
- Optical property measurements using broadband reflectance spectroscopy in human tisues before and after photodynamic therapy (2002) (1)
- In vitro/in vivo radiation protection by nitroxide stable free radicals (1990) (1)
- (S010) Stereotactic Body Radiotherapy (SBRT) for Operable vs. Medically Inoperable Stage I Non-Small Cell Lung Cancer: Long-Term Five-Year Outcomes and an Assessment by Fractionation Regimen, Tumor Size, and Tumor Location (2017) (1)
- Intraperitoneal photodynamic therapy for peritoneal carcinomatosis and sarcomatosis (2000) (1)
- Linked statistical shape models for multi-modal segmentation: application to prostate CT-MR segmentation in radiotherapy planning (2011) (1)
- Diffuse optical measurements of tissue blood flow and oxygenation during interstitial prostate PDT (2006) (1)
- Beating cardiomyocytes are protected by 5-and 6-membered carbocyclic nitroxides against oxidative damage (1990) (1)
- Adjuvant Radiotherapy (RT) for Thymoma: A Dosimetric Comparison of Photon and Proton Based Treatment Techniques (2011) (1)
- Clinical outcomes of elective nodal irradiation (ENI) compared with involved field radiotherapy (IFRT) in NSCLC. (2009) (1)
- An Internet-Based, Multimedia Informed Consent Resource for Proton Therapy Clinical Trials: A Pilot Study (2011) (1)
- Abstract 1871: “Capturing the elusive foe”: A novel telomerase promoter-based approach to detect melanoma circulating tumor cells (2014) (1)
- Beating Cardiomyocytes against Oxidative Damage (1991) (1)
- Poster Viewing7-year Follow-Up Outcomes After Stereotactic Ablation Radiation Therapy for Stage I NSCLC: Results of a Phase 2 Clinical Trial (2017) (1)
- Abstract 4745: Circulating cytokine levels predictive of Grade≥3 radiation pneumonitis: Preliminary secondary analysis of a randomized controlled trial of definitive chemoradiation in locally advanced NSCLC (2017) (1)
- Treatment of Mesothelioma with Radiotherapy (2005) (1)
- Poster ViewingDeveloping a Culture of Safety in a Large Academic Radiation Oncology Practice Through Strategic Implementation of Anonymous and Non-anonymous Reporting Systems (2017) (1)
- Corrigendum: “Training Global Oncologists: Addressing the Global Cancer Control Problem” (2015) (1)
- Survival Signaling Through Nuclear Epidermal Growth Factor Receptor and STAT3 Mediates Photodynamic Therapy Resistance in Ovarian and Lung Cancer Cells (2007) (1)
- Association of changes in vaginal microbiome with oligoclonal T-cell expansion and early response to chemoradiation for cervical cancer. (2018) (1)
- Radiation-Induced Malignant Mesothelioma: Frequency and Prognosis : Mesothelioma, Thymic Malignancies, and Other Thoracic Malignancies (2014) (1)
- A Telomerase-based Assay Tracks Changes in Circulating Tumor Cells in Patients Undergoing Radiation Therapy (2012) (0)
- OC-0613 Spatial dose patterns of radiation pneumonitis in lung cancer patients treated by photons or protons (2019) (0)
- OC-0144: Dosimetric analysis of randomized lung proton and photon plans with respect to radiation toxicity (2017) (0)
- Electron Paramagnetic Resonance Imaging of Tumor Heterogeneity and Oxygà © nationin a Murine Model 1 (2006) (0)
- The protection role of tiron against oxidative damage in mammalian cells (1990) (0)
- OC-0097: Dose patterns associated to pericardial effusion in NSCLC patients treated with radiation therapy (2020) (0)
- Poster ViewingStereotactic Ablative Body Radiation for Pulmonary Metastases: Outcomes Based on Histology and Prognostic Factors (2017) (0)
- Eli J. Glatstein: Inspiring and Provoking Critical Thinking (2020) (0)
- Creation of a Secure HIPAA-compliant Bioinformatics System to Support a Bi-institutional Biomarker Discovery and Correlative Quality of Life Study (2009) (0)
- Mechanism of cytoprotection by Mn(III)-desferrioxamine superoxide dismutase mimic (1990) (0)
- When Failure is Final: Subsequent Outcomes of Patients with Stage I NSCLC who Fail Initial Stereotactic Body Radiation Therapy Monitored with Circulating Tumor Cells (2020) (0)
- Proton Beam Scanning for Mediastinal Lymphoma (2015) (0)
- PH-0285: NTCP models for severe radiation induced dermatitis after thoracic radiation therapy (2020) (0)
- COMMENTARY Development of Investigational Radiation Modifiers (2003) (0)
- EP-1571: Radiotherapy treatments using a prototype MLC design (2017) (0)
- A phase II trial of intraperitoneal photodynamic therapy after debulking surgery for the treatment of disseminated intraperitoneal malignancies (1998) (0)
- Abstract A52: Radiation and dual PD-L1 and CTLA4 checkpoint blockade non-redundantly improves tumor resistance, response, and immunity (2015) (0)
- Clinical applications for photodymanic therapy in oncology (2001) (0)
- Abstract 569: MicroRNA-mediated resistance to anti-PD1 therapy in lung cancer (2016) (0)
- Effect of Thermal History on the Deformation and Fracture of a Semicrystalline-Glassy Block Copolymer* (2001) (0)
- INVASIVE STAGING FOR MESOTHELIOMA REVEALS RADIOGRAPHICALLY OCCULT DISTANT METASTATIC DISEASE (2006) (0)
- Fluence rate variability among light delivery devices for esophageal photodynamic therapy (2007) (0)
- PD01.20 Medicaid Outcome Inequalities in Small Cell Lung Cancer (2019) (0)
- Measuring cost in the value equation using time-driven activity-based costing (TDABC) at The University of Texas MD Anderson Cancer Center, Division of Radiation Oncology. (2017) (0)
- Photosensitizer uptake, tumor oxygenation and clinical outcome in a phase II trial of photofrin (PF)-mediated intraperitoneal photodynamic therapy (IP PDT). (2004) (0)
- Hemithoracic Radiotherapy After Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma: A Tale of Two Techniques (2007) (0)
- Detection of Circulating Tumor Cells of Nonepithelial Origin: A Bench to Bedside Approach (2013) (0)
- Factors Associated With Event Reporting in the Pediatric Radiation Oncology Population Using an Electronic Condition Reporting System (2014) (0)
- SU‐FF‐T‐299: Investigation of Near Surface Doses in Mesothelioma Intensity Modulated Radiation Therapy (2006) (0)
- Abstract 5123: Multiplex in situ immunoprofiling and survival outcomes in non-small cell lung cancer (2016) (0)
- A Circulating Tumor Cell Assay for Tracking Treatment Response in Glioma (2014) (0)
- The Prognostic Role of Hypoxia in Head and Neck Squamous Cell Tumors, as Measured by EF5, is Influenced by EF5 Binding Patterns (2005) (0)
- Multimodality Management of Malignant Pleural Mesothelioma (2010) (0)
- PATTERNS OF RECURRENCE AND SURVIVAL FOLLOWING SURGICAL RESECTION AND INTRAOPERATIVE PHOTODYNAMIC THERAPY(PDT) FOR STAGE IIIB NON-SMALL CELL LUNG CANCER (2006) (0)
- Operations Management in Radiation Oncology: Standardizing Radiation Treatment Scheduling Timelines Using a Data-Driven Tier System (2019) (0)
- Predictive Factors for Mediastinal Nodal Failure in Locally-advanced Non–small–cell Lung Cancer (NSCLC) Patients Receiving Definitive Radiotherapy (RT) (2009) (0)
- The Low-Dose Bath Paradox: Do Spatial Irradiation Patterns Play a Role in the Incidence of Radiation Pneumonitis Following PSPT or IMRT? (2019) (0)
- In vivo determination of the lutetium texaphyrin concentration in canine using fluorescence technique (2000) (0)
- Welcome to the Chicago Multidisciplinary Symposium in Thoracic Oncology (2012) (0)
- Intensity Modulated Radiation Therapy for the Treatment of Malignant Mesothelioma (2007) (0)
- Dose-limiting Pneumonitis in a Phase I Trial of R115777 and Radiation Therapy (RT) for Patients (Pts) with Non-small Cell Lung Cancer (NSCLC) (2008) (0)
- Malignant Pleural Mesothelioma Patients’ Willingness to Participate in a Randomized Controlled Trial of Radical Pleurectomy With or Without Intraoperative Photodynamic Therapy (2013) (0)
- TH‐C‐230A‐07: Reconstruction of Spatially Varying Optical Properties of Human Prostate During Metexafin Lutetium PDT (2006) (0)
- PhotodynamicTherapy: A Light in the Darkness? (2009) (0)
- 2019 Preliminary results of a phase I trial of the 2-nitroimidazole, EF5, an agent for the detection of tumor hypxia (1999) (0)
- Reply to G. Gandaglia et al and K. Lu. (2015) (0)
- Poster ViewingTime-Driven Activity-Based Costing (TDABC) in Radiation Oncology: A Method for Implementation (2017) (0)
- The Implementation and Assessment of a Quality and Safety Culture Education Program in a Large Radiation Oncology Department (2015) (0)
- Phase II study of pleural photodynamic therapy as a component of multimodality therapy for non-small cell lung cancer (2000) (0)
- Persistence of Circulating Tumor Cells as a Biomarker for Recurrent Disease Following Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer (2019) (0)
- SU-E-T-267: Proton Pencil Beam Scanning for Mediastinal Lymphoma: 4-Dimensional Feasibility Study. (2014) (0)
- Poster ViewingThe Proton Insurance Approval Process for Thoracic Patients: Metrics and Access (2017) (0)
- PROSPECT FOR MODIFYING THE RADIOSENSITIVITY OF OXIC TUMOR CELLS (1992) (0)
- Metastatic Non-lung Cancer Carcinomas and Sarcomas Treated with Photodynamic Therapy –A Phase II Study (2004) (0)
- 2588 : A Phase I/II Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of MTS-01 for the Prevention of Alopecia Induced by Whole Brain Radiotherapy (WBRT) (2006) (0)
- Definitive Dose Thoracic Radiotherapy In Oligometastatic Stage IV Non-small Cell Lung Cancer (NSCLC) (2011) (0)
- Supplement to Citizen Petition Docket No. FDA-2013-P-0435 Prohibit Menthol as a Characterizing Flavoring of Cigarettes and Cigarette Smoke (2021) (0)
- 2616 : The HIV Protease Inhibitor Nelfinavir Inhibits Proteasome Activity Resulting in the Unfolded Protein Response and Down-Regulation of Phosphorylated Akt (2006) (0)
- Use of nitroxides and oxazolidines ionizing radiation to protect and oxidative stress (1991) (0)
- EDITORIALS and PDT Combination Therapy for Ovarian Cancer: The Play's the Thing (2005) (0)
- (S046) Long-Term Outcome and Toxicity of Stereotactic Ablative Body Radiotherapy (SABR) for Liver Metastases From Solid Tumors (2017) (0)
- Pre-Treatment Circulating Tumor Cell Levels Correlate with Regional and Distant Failure Rates Following Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancer (2019) (0)
- Academic radiation oncology faculty recruitment: a chair's perspective. (2014) (0)
- Prospective Assessment of Circulating Tumor Cells (CTCs) as a Biomarker for Treatment Failure in Patients with Clinical Stage I Non-Small Cell Lung Cancer (NSCLC) Treated with Stereotactic Body Radiation Therapy (SBRT) (2017) (0)
- Proton therapy and sarcomas (2021) (0)
- A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours (2018) (0)
- 176 P27 is a molecular tumor marker prognostic for survival in 118 NSCLC patients (PTS) treated with radiation t chemotherapy on ECOG3590 (2006) (0)
- PO-0921: Dose considerations of IGRT using MV projection and MV CBCT on a prototype linear accelerator (2017) (0)
- The Need for and Future of Clinical Studies of Proton Therapy (2010) (0)
- Use of nitroxids and oxazolidins for the protection against ionizing radiation and oxidative stress. (1991) (0)
- Examining Patient Perceptions of Quality and Safety in a Large Radiation Oncology Department (2015) (0)
- Long-term results of a phase I/II trial of nelfinavir with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer. (2018) (0)
- 584 Phase II trial design for radiation (XRT) modifiers: efficient evaluation of safety, XRT modifier effect, post-XRT cytostatic effect and relevant molecular markers (2004) (0)
- Research-Driven Radiation Oncology: A Narrative on the Ongoing Legacy of Henry S. Kaplan (2021) (0)
- Association of in-vivo and ex-vivo measurements of tissue oxygenation and photosensitizer concentration in patients with intraperitoneal caracinomatosis (2006) (0)
- Stereotactic Ablative Radiotherapy is a Highly Effective Treatment for Early Stage Non-Small Cell Lung Cancer in Elderly Patients (2018) (0)
- Clinical application of an IR navigation system for pleural PDT (2011) (0)
- The COVID-19 dilemma: enough blood versus convalescent plasma? (vol 148, 10.4067/S0034-98872020000600721, 2020) (2020) (0)
- A method to improve reconstruction of the distribution of hemoglobin, oxygenation, and MLu concentration in the human prostate before and after photodynamic therapy (2007) (0)
- Preliminary results of a telomerase-based circulating tumor cell assay in prostate cancer patients undergoing definitive radiotherapy. (2014) (0)
- Single-Fraction Stereotactic versus Conventional Multifraction Radiation for Predominantly Non-Spine Bone Metastases: A Randomized Phase II Trial (2019) (0)
- Polymorphisms of BMP4 and HIF-1A Are Associated With Patient-Reported Symptoms in Non-Small-Cell Lung Cancer Patients Treated With Definitive Chemoradiation Therapy (2016) (0)
- Inhibiting Signal Transduction as an Approach to Radiosensitizing Tumor Cells (2003) (0)
- Disclosure patterns for unconventional medical therapy use in prostate cancer patients: Standard history vs. directed questioning (2000) (0)
- 125 The role of invasive staging in determining the management of pleural mesothelioma (2006) (0)
- TH‐D‐M100J‐02: Quantitative Interstitial Multispectral Diffuse Optical Tomography of Human Prostate Using a Priori Structure Information (2007) (0)
- Arylcyclobutene-containing compositions and polymeric compositions that are prepared therefrom. (1987) (0)
- Rapid in-vivo measurement of optical and physiological properties in human intraperitoneal tissues before and after photodynamic therapy (2004) (0)
- Fabrication and Properties of Thermoset Films Derived from Bis-Benzocyclobutene for Multilayer Applications (1989) (0)
- Brominated butadiene / vinyl aromatic copolymers, blends of such copolymers with a vinyl aromatic polymer and formed of such mixtures polymer foams (2006) (0)
- Benzocyklobuten-based organosilanadhaesionshjaelpemidler (1989) (0)
- Strengthening Epoxy/High Impact Polystyrene Interfaces Using End Grafting Polymer Chains (1996) (0)
- Deformation and fracture of semicrystalline-glassy block copolymers: Effect of microdomain orientation for cylindrical morphology (2004) (0)
- A process for the hydrogenation of aromatic polymers (1996) (0)
- Physical and Morphological Characterization of Templated Thermosets (2005) (0)
- Thermoplastic Optical Polymers with Lead-Free Solder Reflow Resistance for HB-LED Packaging and Assembly (2010) (0)
- TU‐C‐214‐01: Image‐Guidance for Pleural Photodynamic Therapy Treatment Planning (2011) (0)
- Mechanical properties of pentablock poly(vinylcyclohexane)- poly(ethylene) (PVCH-PE) copolymer systems. (2000) (0)
- SU-E-T-437: Interfractional Dosimetric Verification of Lung Patients Treated by Passive Double Scattering Proton Radiotherapy. (2012) (0)
- Deformation and Fracture of Lamellar PCHE-PE Block Copolymers: Effect of Chain Architecture (2003) (0)
- The compositions Arylcyklobutendel innehaollande, Science Polymer from these two compositions have framstaellda. (1987) (0)
- Fracture of Semicrystalline-Glassy Block Copolymers: Chain Architecture Effects (2000) (0)
- Characterization of the Block Microstructure in Block Copolymer Ionomers Using Small Angle X-Ray Scattering (1994) (0)
- Butadiene / vinyl aromatic brominated, mixtures of such copolymers with a vinyl aromatic polymer, and polymeric foams formed from such mixtures. (2006) (0)
- Diffusion Capacity of the Lungs Following Passive-Scattering Proton Therapy and Intensity-Modulated Photon Radiation Therapy for Locally Advanced Non–small Cell Lung Cancer (2017) (0)
- 3A.02 Major Drivers of Combined Modality Therapy for Limited-Stage Small Cell Lung Cancer in the United States National Cancer Database:Topic: Radiation Oncology (2017) (0)
- Gender, Professional Experiences, and Personal Characteristics of Academic Radiation Oncology Chairs (2018) (0)
- Safety and Efficacy of Stereotactic Body Radiation Therapy (SBRT) Reirradiation for New or Recurrent Pulmonary Malignancies Following Previous In-Field Conventionally Fractionated Thoracic Radiation Therapy (CFRT): Locally Advanced Non-Small Cell Lung Cancer (2014) (0)
- Effect of chemoradiation for cervical cancer on transient decrease and variable expansion in T-cell infiltrate and diversity of T-cell repertoire. (2017) (0)
- Phase I trial of the novel platinum analog ZD0473 in combination with gemcitabine in patients with advanced cancer (2001) (0)
- Proton Irradiation Modulates Tumor Phenotype Leading to Enhanced Immune-Mediated Cell Killing (2015) (0)
- Response, Resistance Mechanisms, and Biomarkers for Radiation and Immune Checkpoint Blockade (2015) (0)
- A Novel Circulating Tumor Cell Assay for Non-Small Cell Lung Cancer Patients Undergoing Radiation Therapy (2013) (0)
- Single-fraction stereotactic versus standard conventional multifraction radiation for predominantly non-spine bone metastases: A randomized phase II trial. (2019) (0)
- Effect of chain architecture and surface energies on the microdomain orientation in block copolymer films (2006) (0)
- Androgen-Deprivation Therapy and Radiation Therapy: Comparative Effectiveness in Real-World Clinical Practice (2013) (0)
- Ras Signaling and Its Inhibition with Farnesyltransferase Inhibitors: Effects on Radiation Resistance and the Tumor Microenvironment (2003) (0)
- OA 08.05 Major Drivers of Chemotherapy and Radiation Utilization for Limited-Stage Small Cell Lung Cancer in the United States (2017) (0)
- Prophylactic Irradiation of Surgical Tract Sites in the Era of Radical Pleurectomy for Malignant Pleural Mesothelioma (2014) (0)
- Late Breaking Abstracts LBA 1 Two Years of AntiAndrogen Treatment Increases Other-Cause Mortality in Men Receiving Early Salvage Radiotherapy : A Secondary Analysis of the NRG Oncology / RTOG 9601 Randomized Phase III Trial (2019) (0)
- t he Body of Evidence f or adv anced t ec hnology in r adiation o ncology (2012) (0)
- Adjuvant Radiotherapy for Completely Resected Stage II Thymoma (2009) (0)
- Abstract 2858: Radiation and dual immune checkpoint blockade overcome tumor resistance and distinctly improve immunity (2015) (0)
- Whither Thou Goest, I Will Go. (2018) (0)
- Photosensitizer uptake, tumor oxygenation and clinical outcome in a phase II trial of photofrin (PF)-mediated intraperitoneal photodynamic therapy (IP PDT) (2004) (0)
- MO-E-BRF-01: Research Opportunities in Technology for Innovation in Radiation Oncology (Highlight of ASTRO NCI 2013 Workshop). (2014) (0)
- Safety and Efficacy of Stereotactic Body Radiation Therapy (SBRT) Reirradiation for New or Recurrent Pulmonary Malignancies Following Previous In-Field Conventionally Fractionated Thoracic Radiation Therapy (CFRT) (2014) (0)
- Patterns and correlates of treatment failure in relation to isodose distribution in non-small cell lung cancer: An analysis of 1522 patients in the modern era. (2017) (0)
- Burnout in Academic Chairs of Radiation Oncology in the United States: The SCAROP Survey (2012) (0)
- Clinical trials of image‐guided interventions including radiotherapy studies (2016) (0)
- Society of Chairs of Academic Radiation Oncology Programs-Endorsed Radiation Oncology Department Review Process. (2015) (0)
- Efficacy and Safety of Stereotactic Body Radiation Therapy (SBRT) for Treatment of Pulmonary Metastases from Sarcoma: A Potential Alternative to Metastatectomy (2014) (0)
- Prophylactic Irradiation of Surgical Tract Sites in the Era of Radical Pleurectomy for Malignant Pleural Mesothelioma : Mesothelioma, Thymic Malignancies, and Other Thoracic Malignancies (2014) (0)
- The pO2 of Cycling Cells is an Independent Predictor of Recurrence and Survival in Human Glioblastomas (2008) (0)
- Estimation of the Molecular Weight between Crosslinks of Crosslinked Semicrystalline Polyolefins (2008) (0)
- Stereotactic Ablative Body Radiation for Pulmonary Metastases: Should We Consider Dose Escalation for More Unresponsive Histologies? (2017) (0)
- Exceptional Response to Radiation Therapy for Cervical Cancers is Associated with Higher Predicted Tumor Neoantigen Burden and Selective Loss of Neoantigens (2019) (0)
- Nitrogen oxides for weight reduction (1991) (0)
- Standardized approach to incident management across a radiation oncology network. (2018) (0)
- Phase 1 Study of Nelfinavir Concurrent With Temozolomide and Radiation Therapy in Patients With Glioblastoma Multiforme (2013) (0)
- A multimodality treatment for malignant pleural mesothelioma patients with or without lymph node metastases. (2010) (0)
- Therapeutic Approaches to Malignant Mesothelioma (2009) (0)
- Comparison of depth dependence of light fluence rate in intralipid for wavelengths between 532-730 nm (2000) (0)
- Poster ViewingReported Outcomes and Toxicities for Inoperable, Stage II-III Non–Small Cell Lung Cancer Patients Treated with Concurrent Chemotherapy and Intensity Modulated Proton Therapy (2017) (0)
- Stereotactic Body Radiation Therapy (SBRT) for Stage I Non-Small Cell Lung Cancer (NSCLC): Outcomes by Fractionation, Tumor Stage and Location, and Patient Operability : Early-Stage Non-Small Cell Lung Cancer (2014) (0)
- Phase 1 Trial of Preoperative Image Guided Intensity Modulated Proton Radiation Therapy (IMPT) With Simultaneously Integrated Boost to the High Risk Margin for Retroperitoneal Sarcomas (2016) (0)
- Proton Pencil Beam Scanning for Mediastinal Lymphoma: Dosimetric Evaluation and 4-Dimensional Robustness Assessment (2014) (0)
- The Impact of Medicaid Insurance on Treatment and Outcomes in Limited-Stage Small Cell Lung Cancer (2019) (0)
This paper list is powered by the following services:
Other Resources About Stephen Hahn
What Schools Are Affiliated With Stephen Hahn?
Stephen Hahn is affiliated with the following schools:
